Page 37 - Central Drug Authority Annual Report 2021
P. 37
2.7 THE COLOMBO PLAN
7KH &RORPER 3ODQ LV RQH RI WKH ROGHVW LQWHUJRYHUQPHQWDO
Programme for the Private Sector: 7KLV SURJUDPPH LV
LQLWLDWLYHV LQ WKH $VLDQ 3DFLˉF 5HJLRQ DQG ZDV RIˉFLDOO\
JHDUHG WRZDUGV SURYLGLQJ WKRVH GHSHQGHQW RQ GUXJV ZLWK D
ODXQFKHG E\ $XVWUDOLD &DQDGD ,QGLD 3DNLVWDQ 1HZ =HDODQG
ȟVHFRQG FKDQFHȠ WR OLYLQJ D OLIH RI TXDOLW\ 7KH SURJUDPPH LV
6UL /DQND DQG WKH 8QLWHG .LQJGRP LQ
WKHUHIRUH FDOOHG WKH 6HFRQG &KDQFH 3URJUDPPH
1) Aims and Objectives of The Colombo Plan
Programme for the Public Administration and Environment:
ȧ 7R SURPRWH LQWHUHVW LQ VXSSRUW RI HFRQRPLF DQG VRFLDO
7KH DFWLYLWLHV RI WKLV SURJUDPPH IRFXV RQ FOLPDWH FKDQJH
DQG WKH HPSRZHUPHQW RI ZRPHQ /RQJ WHUP 6FKRODUVKLSV
GHYHORSPHQW LQ PHPEHU VWDWHV
3URJUDPPH 7KLV SURJUDPPH SURYLGHV VFKRODUVKLSV WR WKRVH
ȧ 7R SURPRWH WHFKQLFDO FR RSHUDWLRQ DQG WKH VKDULQJ RI
LQ QHHG
technology among member states, and
• 7R UHYLHZ WKH UHOHYDQW LQIRUPDWLRQ ,W DOVR DLPV WR
2.8 ISSUP GLOBAL
IDFLOLWDWH WKH WUDQVIHU DQG VKDULQJ RI GHYHORSPHQW
experiences among member countries, especially
WKRVH LQ WKH VRXWKHUQ KHPLVSKHUH
,6683 *OREDO ZDV LQLWLDWHG LQ WKURXJK ,1/ ZRUNLQJ LQ
FRQVXOWDWLRQ ZLWK WKH $IULFDQ 8QLRQ 2$6 &,&$' &RORPER
2) Programmes of Colombo Plan
3ODQ 812'& DQG :+2 ,W ZDV HVWDEOLVKHG LQ WKH 8QLWHG
.LQJGRP DV D QRW IRU SURˉW FRPSDQ\ OLPLWHG E\ JXDUDQWHH LQ
7KH IRXU SHUPDQHQW SURJUDPPHV FDUULHG RXW E\ WKH &RORP-
)HEUXDU\ ,W LV D XQLTXH LQLWLDWLYH RIIHULQJ DQ LQWHUQD-
ER 3ODQ DUH
tional and credible professional membership that brings
WRJHWKHU ERWK WKH WUHDWPHQW DQG SUHYHQWLRQ ZRUNIRUFH
7KH 'UXJ $GYLVRU\ 3URJUDPPH '$3
concerned with substance abuse,
7KH 3URJUDPPH IRU 3XEOLF $GPLQLVWUDWLRQ DQG
(QYLURQPHQW DQG 7KH 3URJUDPPH IRU
7KH ,6683 DLPV WR SURYLGH SURIHVVLRQDOV ZRUNLQJ LQ SXEOLF
3ULYDWH 6HFWRU 'HYHORSPHQW DQG WKH /RQJ WHUP
WUHDWPHQW FHQWUHV DQG SUHYHQWLRQ ˉHOGV ZLWK WUDLQLQJ WR
6FKRODUVKLSV 3URJUDPPH
HTXLS WKHP ZLWK VNLOOV DQG NQRZOHGJH WR FRPEDW 6XEVWDQFH
8VH 'LVRUGHUV ,W HQDEOHV WKHVH SURIHVVLRQDOV WR DSSO\
3) The Link between the CDA and the Colombo Plan
VFLHQFH PDNLQJ LW DFFHVVLEOH DQG FRPSUHKHQVLEOH IRU HYHU\-
7KH &'$ KDV VXSSRUWHG WKH &RORPER 3ODQ LQLWLDWLYHV
RQH ZLWKLQ WKH LQWHUQDWLRQDO GUXJ WUHDWPHQW DQG SUHYHQWLRQ
SURJUDPPHV DQG WUDLQLQJ VHVVLRQV ZLWKLQ 6RXWK $IULFD 2QFH
FRPPXQLW\ ,W LV DOVR SURIHVVLRQDOLVLQJ WKH SUHYHQWLRQ DQG
DFFUHGLWHG E\ WKH 6RXWK $IULFDQ 4XDOLˉFDWLRQV $XWKRULW\
treatment workforce, to promote quality standards, ethical,
6$4$ WKH YDULRXV SURJUDPPHV VKRXOG EH YDOXDEOH WRROV LQ
DQG HYLGHQFH EDVHG SUDFWLFH ,W LV DQ LQWHUQDWLRQDO RUJDQLVD-
WKH &'$ȠV HIIRUWV WR VWUHQJWKHQ LWV VXSSRUW VWUXFWXUHV 36$)V
tion that was set up to meet the needs and challenges faced
DQG /'$&V
E\ WKH SUHYHQWLRQ DQG WUHDWPHQW ZRUNIRUFH
The key characteristics of these programmes are as follows:
)LQDOO\ SUHYHQWLRQ DQG WUHDWPHQW VFLHQFH KDV PRYHG
Drug Advisory Programme (DAP): 7KLV SURJUDPPH DLPV WR
VXEVWDQWLDOO\ RYHU UHFHQW \HDUV 7KH IROORZLQJ DUH WKH UHFHQW
build capacity for drug demand reduction in the Asian and
FRXUVHV WKDW DUH DLPHG DW SURYLGLQJ SURIHVVLRQDOV ZLWK
3DFLˉF 5HJLRQ ,W HQFRXUDJHV QDWLRQDO HIIRUWV DPRQJ
continuing education and sharpening their skills and knowl-
PHPEHU FRXQWULHV WRZDUGV GHPDQG UHGXFWLRQ '$3 LQLWLD-
HGJH LQ WKH ˉHOG
WLYHV LQFOXGH WKH HVWDEOLVKPHQW RI QDWLRQDO GUXJ IRFDO
8QLYHUVDO 3UHYHQWLRQ &XUULFXOXP
points, the formulation of national drug policy, the imple-
8QLYHUVDO 7UHDWPHQW &XUULFXOXP
PHQWDWLRQ RI GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYHV WKH LQLWLD-
,W LV LPSRUWDQW WR VWDWH WKDW WKH FRXUVHV DERYH ZHUH VXSSRUW-
WLRQ RI WKH $IJKDQ GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYH DQG WKH
HG E\ ,1/ DQG WKH &RORPER 3ODQ
$VLDQ &HQWUH IRU &HUWLˉFDWLRQ DQG (GXFDWLRQ RI $GGLFWLRQ
3URIHVVLRQDOV $&&(
7KH (XURSHDQ 'UXJ 3UHYHQWLRQ 4XDOLW\ 6WDQGDUGV LV IXQGHG
E\ WKH (XURSHDQ 8QLRQ DQG XQGHUWDNHQ E\ WKH (XURSHDQ
The ACCE initiatives ZHUH HVWDEOLVKHG LQ DV WKH
3UHYHQWLRQ 6WDQGDUGV 3DUWQHUVKLS DQG WKH ,QWHUQDWLRQDO
WUDLQLQJ DQG FUHGHQWLDOLQJ DUP RI WKH '$3 7KH $&&( LV DQ
6WDQGDUGV RQ 'UXJ 8VH 3UHYHQWLRQ SURGXFHG E\ 812'&
LQWHJUDO SDUW RI WKH JOREDO LQLWLDWLYH IXQGHG E\ WKH %XUHDX
IRU ,QWHUQDWLRQDO 1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV RI
WKH 86 'HSDUWPHQW RI 6WDWH
CHAPTER 4 - NDMP 2019 - 2024 IMPLEMENTATION ANALYSIS
,6683 LPSOHPHQWV LWV DFWLYLWLHV LQ FRQVXOWDWLRQ ZLWK 2.9 INTERNATIONAL NETWORK ON HEPATITIS IN
&DQDGLDQ &HQWUH RQ 6XEVWDQFH $EXVH &&6$ SUBSTANCE USERS (INHSU) 7KLV FKDSWHU ZLOO PHDVXUH WKH SHUIRUPDQFH RI QDWLRQDO 6WLPXODWH UREXVW DQG VXVWDLQDEOH HFRQRPLF JURZWK
&RORPER 3ODQ GHSDUWPHQWV DQG 3URYLQFLDO 6XEVWDQFH $EXVH )RUXPV WKH DLPHG DW UHGXFLQJ SRYHUW\ XQHPSOR\PHQW DQG
&RRSHUDWLRQ 3URJUDPPH RQ 'UXJV 3ROLFLHV &232/$' ,1+68 LV DQ LQWHUQDWLRQDO RUJDQLVDWLRQ GHGLFDWHG WR ODWWHU LQFRUSRUDWLQJ DOO LQSXWV IURP /RFDO 'UXJ $FWLRQ LQHTXDOLWLHV
(XURSHDQ 0RQLWRULQJ &HQWUH IRU 'UXJV DQG 'UXJ VFLHQWLˉF NQRZOHGJH H[FKDQJH NQRZOHGJH WUDQVODWLRQ DQG &RPPLWWHHV QRQ JRYHUQPHQWDO RUJDQLVDWLRQV RSHUDWLRQDO LQ
$GGLFWLRQ (0&''$ DGYRFDF\ IRFXVHG RQ KHSDWLWLV & SUHYHQWLRQ DQG FDUH IRU WKH SURYLQFH DJDLQVW WKH JRDOV DQG REMHFWLYHV RI WKH 1'03 National Conference on Substance Abuse and Family Related
,W PXVW EH QRWHG KRZHYHU WKDW QRW DOO GHSDUWPHQWV VXEPLW-
(XURSHDQ 6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK (8635 SHRSOH ZKR XVH GUXJV ,QFUHDVLQJ KHSDWLWLV & WHVWLQJ OLQNDJH WHG UHSRUWV 6RPH RWKHU GHSDUWPHQWV GR QRW KDYH UHSUHVHQ- Interventions Conference Resolutions
2UJDQLVDWLRQ RI $PHULFDQ 6WDWHV ,QWHU $PHULFDQ 'UXJ to care, treatment and cure among people who use drugs is WDWLRQ LQ WKH &'$ \HW DV QR QRPLQDWLRQV KDYH \HW EHHQ
Abuse Control Commission ( RI SDUDPRXQW LPSRUWDQFH 7KLV LV DQ LQLWLDWLYH WKDW WKH &'$ UHFHLYHG IURP WKH DIIHFWHG GHSDUWPHQWV 'HYHORS DQG LPSOHPHQW WKH OHJDO IUDPHZRUN WR
VXSSRUWV
6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK 635 UHVWULFW DFFHVV WR DQG DYDLODELOLW\ RI DOFRKRO
7KH (XURSHDQ 3UHYHQWLRQ 6WDQGDUGV 3DUWQHUVKLS 7KH H[WHQW WR ZKLFK WKH &'$ ZDV DEOH WR H[SORUH DQG H[SORLW 7KH DQDO\VLV RI UHSRUWV 1DWLRQDO 'HSDUWPHQWV DQG 3URYLQFLDO 6WUHQJWKHQ PHFKDQLVPV WR PLQLPL]H WKH LOOHJDO
PDQXIDFWXULQJ VXSSO\ DQG DOO IRUPV RI WUDIˉFNLQJ RI
8QLWHG 1DWLRQV 2IˉFH RQ 'UXJV DQG &ULPH 812'& WKHVH SDUWQHUVKLSV DQG UHODWLRQVKLSV KDV QRW EHHQ RSWLPDO 6XEVWDQFH $EXVH )RUXPV RQ WKH LPSOHPHQWDWLRQ RI WKH licit and illicit drugs;
8 6 'HSDUWPHQW RI 6WDWHȠV %XUHDX RI ,QWHUQDWLRQDO ,QGLYLGXDO GHSDUWPHQWV ZHUH KRZHYHU DEOH WR IRUJH 1DWLRQDO 'UXJ 0DVWHU 3ODQ IRU WKH UHSRUWLQJ 6WUHQJWKHQ WKH FROODERUDWLRQ DQG FRRUGLQDWLRQ
1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV ,1/ relationships and interact with these agencies in line with SHULRG $SULO WR 0DUFK LV EDVHG RQ WKH PHFKDQLVPV WR ˉJKW WKH VFRXUJH RI VXEVWDQFH
:RUOG +HDOWK 2UJDQLVDWLRQ :+2 VHFWRU SROLFLHV DQG VHUYLFH GHOLYHU\ PDQGDWHV DV LQGLFDWHG LQ 2XWFRPHV RI WKH 0HGLXP 7HUP 6WUDWHJLF )UDPHZRUN use/abuse;
WKH GHSDUWPHQWDO DQG VHFWRU UHSRUWV EHORZ 076) RI WKH 1DWLRQDO 'HYHORSPHQW 3ODQ WKH ,PSOHPHQW DQ LQWHJUDWHG DQG EDODQFHG DSSURDFK WKDW
*RDOV RI WKH 1'03 DQG WKH 5HVROXWLRQV RI WKH includes demand and supply reduction strategies
1DWLRQDO &RQIHUHQFH RQ 6XEVWDQFH $EXVH DQG )DPLO\ 5HODW- required, including international cooperation;
HG ,QWHUYHQWLRQV KHOG LQ (NXUKXOHQL RQ WKH VW 2FWREHU ȝ ,QFUHDVH LQYHVWPHQW LQ KHDOWK SUHYHQWLRQ HDUO\
QG 1RYHPEHU
LQWHUYHQWLRQ WUHDWPHQW DQG UHKDELOLWDWLRQ DQG DIWHU
FDUH VHUYLFHV
NDP MTSF Outcomes
0DLQVWUHDP PRUDO UHJHQHUDWLRQ DQG UHVWRUDWLRQ LQ DOO
VXEVWDQFH DEXVH SURJUDPPHV DQG VHUYLFHV
$FFRUGLQJ WR WKH 076) WKH FRPELQDWLRQ RI REMHFWLYHV ZLOO LQ ,PSURYH GDWD FROOHFWLRQ DQG XVH VXUYHLOODQFH V\VWHP
WKH PHGLXP WHUP FRQWULEXWH WR LPSURYHG KHDOWK KXPDQ IRU HYLGHQFH EDVHG SODQQLQJ DQG SURJUDPPLQJ
ULJKWV GHYHORSPHQW DQG VHFXULW\ RXWFRPHV RI SHRSOH ZKR 0RELOL]H DQG LQYROYH FRPPXQLWLHV LQFOXGLQJ )%2V
XVH GUXJV LQ FRPPXQLWLHV 7KH 1'03 ZLOO EH 1*2V &%2V DFDGHPLFV ODERXU EXVLQHVV UHVHDUFK
H[SOLFLWO\ HYDOXDWHG RQ WKH H[WHQW WR ZKLFK WKH SODQ FRQWULE- LQVWLWXWLRQV HWF WR VWUHQJWKHQ IDPLOLHV LQ WKH ˉJKW
XWHV WR RU DFKLHYHV WKHVH RXWFRPHV against the scourge;
ȧ 2XWFRPH 5HGXFHG OHYHOV RI SRYHUW\ 6WUHQJWKHQ UHJLRQDO FRQWLQHQWDO DQG LQWHUQDWLRQDO
ȧ 2XWFRPH 5HGXFHG OHYHOV RI LQHTXDOLW\ cooperation; and
ȧ 2XWFRPH 5HGXFHG VRFLDO LOOV LPSURYHG ZHOO EHLQJ ,QFUHDVH WKH WD[ RI DOFRKRO EHYHUDJHV WR ˉJKW DOFRKRO
RI FKLOGUHQ IDPLOLHV DQG FRPPXQLWLHV related harm;
ȧ 2XWFRPH (PSRZHUHG UHVLOLHQW LQGLYLGXDOV IDPLOLHV (QVXUH HTXDO DFFHVV DQG GLVWULEXWLRQ RI UHVRXUFHV
DQG VXVWDLQDEOH FRPPXQLWLHV HVSHFLDOO\ IRU FLYLO VRFLHW\ DQG RUJDQLVDWLRQV IURP
ȧ 2XWFRPH ,PSURYHG VHFWRU FDSDELOLW\ informal settlement, urban and rural areas; and
$FFHOHUDWH LQ WKH VSLULW RI .KDXOH]D WKH
NDMP 2019- 2024 Goals LPSOHPHQWDWLRQ RI WKHVH FRPPLWPHQWV WR JLYH HIIHFW
WR WKH 1DWLRQDO 'UXJ 0DVWHU 3ODQ DW DOO VSKHUHV RI
'HPDQG UHGXFWLRQ DQG UHODWHG PHDVXUHV LQFOXGLQJ WKH JRYHUQPHQW
SUHYHQWLRQ DV ZHOO DV RWKHU KHDOWK UHODWHG LVVXHV
6XSSO\ UHGXFWLRQ DQG UHODWHG PHDVXUHV HIIHFWLYH ODZ 7KH DERYH ZLOO EH XVHG DV PHDVXUHV DJDLQVW ZKLFK UHSRUWV
enforcement; responses to drug related crime; and E\ WKH QDWLRQDO GHSDUWPHQWV DQG 3URYLQFLDO 6XEVWDQFH
countering money laundering and promoting judicial )RUXPV ZLOO EH DQDO\VHG 7KHVH PHDVXUHV ZLOO EH UHˊHFWHG
cooperation; LQ WKH UHOHYDQW FROXPQV LQ WKH WDEOHV EHORZ
(QVXULQJ WKH DYDLODELOLW\ RI DQG DFFHVV WR FRQWUROOHG
VXEVWDQFHV H[FOXVLYHO\ IRU PHGLFDO DQG VFLHQWLˉF
SXUSRVHV ZKLOH SUHYHQWLQJ WKHLU GLYHUVLRQ
,GHQWLˉFDWLRQ DQG FRQWURO RI QHZ SV\FKRWURSLF SV\-
FKRDFWLYH VXEVWDQFHV
3URPRWH JRYHUQDQFH OHDGHUVKLS DQG DFFRXQWDELOLW\
IRU D FRRUGLQDWHG PXOWL VHFWRUDO HIIHFWLYH UHVSRQVH
6WUHQJWKHQ GDWD FROOHFWLRQ PRQLWRULQJ HYDOXDWLRQ DQG
UHVHDUFK HYLGHQFH WR DFKLHYH WKH JRDOV DQG
Annual Report 2020/2021 Central Drug Authority 35